Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Obesity (Silver Spring, Md.)|June 11, 2011
Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetesPadma Sathyanarayana, Medhavi Jogi, Raja Muthupillai, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetesMandeep Bajaj, Swangjit Suraamornkul, Sangeeta Kashyap, et al.
Atherosclerosis|June 13, 2012
The effect of pioglitazone treatment on 15-epi-lipoxin A4 levels in patients with type 2 diabetesAbsalon D Gutierrez, Padma Sathyanarayana, Somasekhar Konduru, et al.
Cardiovascular Drugs and Therapy|August 27, 2021
SGLT2 Inhibition by Dapagliflozin Attenuates Diabetic Ketoacidosis in Mice with Type-1 DiabetesHuan Chen, Yochai Birnbaum, Regina Ye, et al.
Current Diabetes Reports|July 12, 2018
SGLT2 Inhibitors and Cardiovascular Outcomes: Current Perspectives and Future PotentialsXiaoming Jia, Paras B Mehta, Yumei Ye, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patientsYoshinori Miyazaki, Archana Mahankali, Estela Wajcberg, et al.
Tropical Doctor|March 20, 2015
Periorbital necrotising fasciitis in infants: Presentation and management of six casesSaurbhi Khurana, Neelam Pushker, Sreedhara S Naik, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 11, 2008
Gene therapy for diabetes: metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse modelSusan L Samson, Erica V Gonzalez, Vijay Yechoor, et al.
Diabetes|March 1, 2007
Paradoxical changes in muscle gene expression in insulin-resistant subjects after sustained reduction in plasma free fatty acid concentrationMandeep Bajaj, Rafael Medina-Navarro, Swangjit Suraamornkul, et al.
Cardiovascular Drugs and Therapy|August 10, 2014
PTEN upregulation may explain the development of insulin resistance and type 2 diabetes with high dose statinsYochai Birnbaum, Manjyot K Nanhwan, Shukuan Ling, et al.
Pageof 6